ad

Pharma Stocks Under Rs 100 and Chemical Picks With Rising Profits: Morepen, Syncom, Fineotex and Meghmani

Morepen Rs 90.55, Syncom Rs 22.09, Fineotex Rs 45.04, Meghmani Rs 53.64 (19 Nov 2026). Q2 FY27 profit up 60.5% to 193.3% for all four.


20 Nov 2026 • 10:43 am

Pharma Stocks Under Rs 100 and Chemical Picks With Rising Profits: Morepen, Syncom, Fineotex and Meghmani

Quick Answer

Morepen Laboratories and Syncom Formulations are two pharma stocks under Rs 100, and Fineotex Chemical and Meghmani Organics are two chemical stocks in the same price range, all with sharply higher September 2026 quarter profits. Profit growth ranged from 60.5% at Syncom to 193.3% at Meghmani. Syncom has the highest return on equity at 20.34%, and Fineotex the lowest debt at a debt-to-equity ratio of 0.01. All four trade below their industry P/E, though raw material prices remain a key swing factor.

India's pharma and chemical industries supply medicines and industrial inputs to the world. Smaller listed companies in these sectors often trade under Rs 100 per share while growing faster than larger peers.

The four stocks below include two pharma stocks under Rs 100 and two chemical companies, all of which reported higher profit in the September 2026 quarter and trade below their industry P/E. Prices are as of the 19 November 2026 NSE close, and financials are from company exchange filings.

Click Here – Get Free Investment Predictions

Which Pharma Stocks Under Rs 100 Have the Strongest Growth?

Morepen Laboratories and Syncom Formulations are the pharma stocks under Rs 100 with the strongest recent growth, with September 2026 quarter profit up 116.6% and 60.5%. Among chemical names in the same price range, Meghmani Organics grew profit 193.3% and Fineotex Chemical 70.8%.

Company Sector CMP (Rs) Market Cap (Rs Cr) P/E Industry P/E ROE Debt-to-Equity
Morepen Laboratories Pharmaceuticals 90.55 4,967 26.35 40.13 13.65% 0.23
Syncom Formulations (India) Pharmaceuticals 22.09 2,076 21.66 40.13 20.34% 0.03
Fineotex Chemical Speciality Chemicals 45.04 5,248 31.52 33.29 13.35% 0.01
Meghmani Organics Agrochemicals and Pigments 53.64 1,366 15.80 22.36 5.32% 0.41

Morepen Laboratories is the largest at Rs 4,967 crore in market capitalisation. Syncom Formulations has the highest return on equity at 20.34%, and Meghmani Organics trades below book value at a P/B of 0.84.

1. Morepen Laboratories: Revenue Up 81.4% in Q2 FY27

Morepen Laboratories grew September 2026 quarter revenue by 81.4% to Rs 755.19 crore and profit by 116.6% to Rs 88.89 crore. Operating margin improved to 17.66%. Annual revenue had already grown from Rs 1,423.66 crore in FY23 to Rs 1,827.01 crore in FY26.

Morepen makes active pharmaceutical ingredients, glucometers and other diagnostic devices, and over-the-counter brands. At Rs 90.55, the stock trades at a P/E of 26.35 against a pharma industry P/E of 40.13, with a debt-to-equity ratio of 0.23 and a return on equity of 13.65%. FY26 profit was below FY25, so the FY27 recovery needs to hold for the full year.

2. Syncom Formulations: ROE of 20.34% and Profit Up 60.5%

Syncom Formulations grew September 2026 quarter profit by 60.5% to Rs 26.65 crore, with revenue up 16.7% to Rs 148.21 crore. Annual profit has nearly quadrupled from Rs 19.79 crore in FY22 to Rs 76.44 crore in FY26.

The company makes tablets, capsules and liquid formulations for India and export markets. Its operating margin has improved to 26.73% from 19.43% a year earlier. With a debt-to-equity ratio of 0.03 and return on equity of 20.34%, Syncom combines low debt with strong returns. At Rs 22.09 it trades at a P/E of 21.66, about half the industry average.

Screen Pharma Stocks Under Rs 100 on the Univest Screener

3. Fineotex Chemical: Speciality Chemicals Revenue Up 169%

Fineotex Chemical's September 2026 quarter revenue rose 169.1% to Rs 391.41 crore and profit rose 70.8% to Rs 44.55 crore. FY26 revenue grew 44.4% to Rs 805.30 crore, and profit has more than doubled since FY22.

Fineotex supplies speciality chemicals for textile processing, home cleaning and hygiene products. The founder family holds 62.3%, and the debt-to-equity ratio is 0.01. At Rs 45.04 it trades at a P/E of 31.52, close to the chemical industry P/E of 33.29. Operating margin has eased to 16.34% as volumes rose, which is the trend to watch.

4. Meghmani Organics: Q2 Profit Up 193.3% on Agrochemical Recovery

Meghmani Organics reported September 2026 quarter profit of Rs 33.88 crore, up 193.3% from Rs 11.55 crore, on revenue up 13.5% to Rs 686.99 crore. The company returned to an annual profit of Rs 28.74 crore in FY26 after losses in FY24 and FY25.

Meghmani makes agrochemicals and pigments, selling to farmers in India and to global customers. Promoters hold 48.95%. At Rs 53.64 the stock trades at 0.84 times book value and a P/E of 15.80 against an industry P/E of 22.36, with a debt-to-equity ratio of 0.41. Agrochemical demand depends on monsoon and global inventory cycles.

Download the Univest iOS App or Univest Android App to track these pharma and chemical stocks live and get daily research.

Why Pharma and Chemical Stocks Under Rs 100 Are Worth Watching

Pharma stocks under Rs 100 and smaller chemical companies benefit from global supply chain shifts toward India, steady domestic healthcare demand and rising exports. Smaller players can grow faster because they start from a lower revenue base.

These sectors also have defensive qualities, as medicines and essential chemicals see steady demand through economic cycles. The Nifty Pharma is a useful benchmark for comparing pharma stock performance.

How to Choose Pharma Penny Stocks in India

  • Margin trend: Rising margins, as at Syncom, show pricing strength or a better product mix.
  • Debt levels: Low debt helps companies fund new capacity and regulatory approvals.
  • Return on equity: Above 15% suggests efficient use of capital.
  • Export exposure: Export-heavy companies benefit from global demand but face currency risk.
  • Valuation: Compare P/E with the pharma industry average of 40.13.

Points to Be Careful About

  • Raw material costs: Chemical and API prices can swing margins quickly.
  • Regulatory approvals: Pharma exports depend on inspections and approvals in importing countries.
  • Seasonal demand: Agrochemical sales at Meghmani depend on the monsoon.

How to Invest in Pharma and Chemical Stocks

  1. Filter pharma stocks under Rs 100 on the Univest Screener by profit growth and ROE.
  2. Check margins and debt over several quarters.
  3. Understand each company's product mix and export share.
  4. Compare P/E with industry averages.
  5. Invest through a SEBI-registered broker such as Univest.

Conclusion

Morepen Laboratories and Syncom Formulations stand out among pharma stocks under Rs 100, while Fineotex Chemical and Meghmani Organics offer chemical sector exposure in the same price range. All four grew September 2026 quarter profit sharply and trade below industry valuations. Raw material costs and margins are the key factors to watch. Review quarterly results and consult a SEBI-registered advisor before investing.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on Pharma Stocks Under Rs 100

Which are the best pharma stocks under Rs 100?

Ans. Morepen Laboratories and Syncom Formulations are two pharma stocks under Rs 100 with strong recent results. Morepen's September 2026 quarter profit rose 116.6% on revenue growth of 81.4%, and Syncom's profit rose 60.5% with a return on equity of 20.34%. Both trade below the pharma industry P/E of 40.13 and carry low debt, which gives them room to invest in growth.

Is Syncom Formulations a good stock?

Ans. Syncom Formulations has strong fundamentals, with a return on equity of 20.34%, a debt-to-equity ratio of 0.03 and annual profit that has nearly quadrupled since FY22 to Rs 76.44 crore. Its operating margin improved to 26.73% in the September 2026 quarter. At Rs 22.09, it trades at a P/E of 21.66, about half the industry average. Consult a SEBI-registered advisor before buying.

What are chemical penny stocks?

Ans. Chemical penny stocks are low-priced shares of companies that make industrial, speciality or agricultural chemicals. Examples in this list include Fineotex Chemical, which makes speciality chemicals for textiles and cleaning, and Meghmani Organics, which makes agrochemicals and pigments. Their profits often depend on raw material prices and export demand, which makes them cyclical.

Why did Meghmani Organics' profit rise so much?

Ans. Meghmani Organics' September 2026 quarter profit rose 193.3% to Rs 33.88 crore as agrochemical demand recovered after a difficult period, and revenue grew 13.5%. The company had reported losses in FY24 and FY25 before returning to a Rs 28.74 crore profit in FY26. The low base from the year-ago quarter also adds to the percentage growth.

Are pharma stocks defensive investments?

Ans. Pharma stocks are often seen as defensive because demand for medicines stays steady through economic cycles. However, smaller pharma companies can still be volatile due to pricing pressure, regulatory inspections and export market changes. Companies with low debt and consistent margins, like Syncom Formulations, tend to handle downturns better. Diversifying across a few pharma names helps reduce company-specific risk.

What should I check before buying a pharma penny stock?

Ans. Check revenue and profit growth over several quarters, operating margin trends, debt levels and return on equity. Also understand the company's products, whether it makes APIs or finished formulations, and how much it relies on exports. Regulatory history with drug authorities in major markets matters for exporters. The Univest Screener lets you compare these metrics across pharma stocks.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down